The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia.

Authors :: Haddad FG
Sasaki K
Issa GC
Jabbour E
Kantarjian H
Source :: American journal of hematology [Am J Hematol] 2024 Jun; Vol. 99 (6), pp. 1175-1176. Date of Electronic Publication: 2024 Mar 28.
Publication Year :: 2024

Subjects :: Humans
Male
Female
Middle Aged
Adult
Aged
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Philadelphia Chromosome
Remission Induction
Chromosome Aberrations

Full Text Access

Tools